Cutaneous T-cell Lymphoma.
Weiner DM, Rook AH.
Hematol Oncol Clin North Am. 2024 Oct;38(5):1087-1110. doi: 10.1016/j.hoc.2024.05.012. Epub 2024 Jul 29.
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M; ALCANZA study group.
Lancet. 2017 Aug 5;390(10094):555-566. doi: 10.1016/S0140-6736(17)31266-7. Epub 2017 Jun 7.
Primary cutaneous anaplastic large cell lymphoma.
Brown RA, Fernandez-Pol S, Kim J.
J Cutan Pathol. 2017 Jun;44(6):570-577. doi: 10.1111/cup.12937. Epub 2017 Apr 25.
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sezary syndrome. Part I: Clinical and histologic features and diagnosis.
Stoll JR, Willner J, Oh Y, Pulitzer M, Moskowitz A, Horwitz S, Myskowski P, Noor SJ.
J Am Acad Dermatol. 2021 Nov;85(5):1073-1090. doi: 10.1016/j.jaad.2021.04.080. Epub 2021 Apr 30.
Primary Cutaneous Anaplastic Large Cell Lymphoma-A Review of Clinical, Morphological, Immunohistochemical, and Molecular Features.
Ortiz-Hidalgo C, Pina-Oviedo S.
Cancers (Basel). 2023 Aug 14;15(16):4098. doi: 10.3390/cancers15164098.
Anaplastic Large Cell Lymphoma.
Kaseb H, Mukkamalla SKR, Rajasurya V.
2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Breast Implant-associated Anaplastic Large Cell Lymphoma.
Alotaibi S, Hamadani M, Al-Mansour M, Aljurf M.
Clin Lymphoma Myeloma Leuk. 2021 Mar;21(3):e272-e276. doi: 10.1016/j.clml.2020.12.005. Epub 2020 Dec 13.
Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood.
Tomaszewski MM, Moad JC, Lupton GP.
J Am Acad Dermatol. 1999 May;40(5 Pt 2):857-61. doi: 10.1053/jd.1999.v40.a95960.
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W, Pfaltz K, Vermeer MH, Cozzio A, Ortiz-Romero PL, Bagot M, Olsen E, Kim YH, Dummer R, Pimpinelli N, Whittaker S, Hodak E, Cerroni L, Berti E, Horwitz S, Prince HM, Guitart J, Estrach T, Sanches JA, Duvic M, Ranki A, Dreno B, Ostheeren-Michaelis S, Knobler R, Wood G, Willemze R.
Blood. 2011 Oct 13;118(15):4024-35. doi: 10.1182/blood-2011-05-351346. Epub 2011 Aug 12.
Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma: A Rare Association With Large Plaque Parapsoriasis.
Manole I, Butacu AI, Negulet IE, Valcoci MC, Tiplica GS.
Cureus. 2020 Oct 28;12(10):e11228. doi: 10.7759/cureus.11228.
